13F HOLDINGS REPORT
Column Group LLC
Quarter ended Q3 2023 · Filed July 24, 2023 · Accession 0000950123-23-006249
Total Value
$257.7M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Revolution Medicines Inc | RVMDW | 2,577,220 | $68.9M | 26.76% |
| 2 | Tenaya Therapeutics, Inc. | TNYA | 9,400,290 | $55.2M | 21.42% |
| 3 | RAPT Therapeutics Inc | 75382E109 | 2,680,621 | $50.1M | 19.45% |
| 4 | NGM Biopharmaceuticals Inc | 62921N105 | 18,136,735 | $47.0M | 18.23% |
| 5 | ORIC Pharmaceuticals Inc. | ORIC | 3,568,181 | $27.7M | 10.75% |
| 6 | Surrozen, Inc. | SRZNW | 9,414,795 | $5.2M | 2.01% |
| 7 | eFFECTOR Therapeutics Inc | 28202V108 | 4,309,329 | $3.6M | 1.39% |